Effect of Uncertainty on Adherence and Quality of Life in Breast Cancer Survivors: A Systematic Review
DOI:
https://doi.org/10.61841/qfw9ff87Keywords:
Uncertainty, Adherence, Quality of life, Breast Cancer SurvivorAbstract
Quality of life takes precedence in the terminal stages of disease, such as breast cancer survivor, when a cure is considered impossible and all alternative methods to prevent disease progression have been exhausted. Given the distress associated with a cancer diagnosis, the treatments and their side effects, as well as the uncertainty of outcomes, it has been suggested that psychosocial factors ought to be considered as an important aspect of breast cancer treatment. The purpose of this research was to assess the effect of uncertainty on adherence and quality of life in breast cancer survivors. A systematic review of the literature concerning uncertainty, adherence and quality of life for patients with breast cancer was conducted by searching PubMed (including Medline), Web of Science, CINAHL Plus, Embase, Breast Cancer Research, The Cochrane Library and Google Scholar Database for articles featuring the terms “uncertainty”, “adherence”, “quality of life”, “cancer” and “breast cancer”. Eligible studies were those whose title or abstract specifically indicated the inclusion of breast cancer patients. There were no restrictions regarding participants’ age, number of participants, or disease stage and the studies were analyzed using prisma. The results of the studies confirmed that the effects of uncertainty were significant, alluding to the possibility to enhance adherence and quality of life in breast cancer survivors. Distress from prognostic uncertainty are associated with adherence and quality of life in breast cancer patients. The findings of this review encourage efforts to further research to enhance quality of care and better quality of life in breast cancer survivors.
Downloads
References
[1] P. Fox et al., “The assessment and management of chemotherapy-related toxicities in patients with breast cancer, colorectal cancer, and Hodgkin’s and non-Hodgkin’s lymphomas: A scoping review,” Eur. J. Oncol. Nurs., vol. 26,
pp. 63–82, 2017, doi: 10.1016/j.ejon.2016.12.008.
[2] Q. Zhang, L. Zhang, R. Yin, T. Fu, H. Chen, and B. Shen, “Effectiveness of telephone-based interventions on health- related quality of life and prognostic outcomes in breast cancer patients and survivors—A meta-analysis,” Eur. J. Cancer Care (Engl)., vol. 27, no. 1, pp. 1–10, 2018, doi: 10.1111/ecc.12632.
[3] M. Jang and J. Kim, “A structural model for stress, coping, and psychosocial adjustment: A multi-group analysis by stages of survivorship in Korean women with breast cancer,” Eur. J. Oncol. Nurs., vol. 33, no. January, pp. 41–48, 2018, doi: 10.1016/j.ejon.2018.01.004.
[4] Y. Jiang, S. M. Sereika, C. M. Bender, A. M. Brufsky, and M. Q. Rosenzweig, “Beliefs in chemotherapy and knowledge of cancer and treatment among African American women with newly diagnosed breast cancer,” Oncol.
Nurs. Forum, vol. 43, no. 2, pp. 180–189, 2016, doi: 10.1188/16.ONF.180-189.
[5] M. Cohen, “First-degree relatives of breast-cancer patients: Cognitive perceptions, coping, and adherence to breast self-examination,” Behav. Med., vol. 28, no. 1, pp. 15–22, 2002, doi: 10.1080/08964280209596394.
[6] K. J. Yost et al., “Adapting a Cancer Literacy Measure for Use Among Navajo Women,” J. Transcult. Nurs., vol. 28, no. 3, pp. 278–285, 2017, doi: 10.1177/1043659616628964.
[7] S. Johansen, M. Cvancarova, and C. Ruland, “The Effect of Cancer Patients’ and Their Family Caregivers’ Physical and Emotional Symptoms on Caregiver Burden,” Cancer Nurs., vol. 41, no. 2, pp. 91–99, 2018, doi: 10.1097/NCC.0000000000000493.
[8] C. X. Aguado Loi et al., “Risk factors associated with increased depressive symptoms among Latinas diagnosed with breast cancer within 5 years of survivorship,” Psychooncology., vol. 22, no. 12, pp. 2779–2788, 2013, doi: 10.1002/pon.3357.
[9] J. Goldberg, J. Hinchey, S. Feder, and D. Schulman-Green, “Developing and Evaluating a Self-Management Intervention for Women With Breast Cancer,” West. J. Nurs. Res., vol. 38, no. 10, pp. 1243–1263, 2016, doi: 10.1177/0193945916650675.
[10] P. Baker, H. Beesley, I. Fletcher, J. Ablett, C. Holcombe, and P. Salmon, “‘Getting back to normal’ or ‘a new type of normal’? A qualitative study of patients’ responses to the existential threat of cancer,” Eur. J. Cancer Care (Engl)., vol. 25, no. 1, pp. 180–189, 2016, doi: 10.1111/ecc.12274.
[11] X. Jiao-Mei, G. Wen, and C. Feng-Lin, “Quality of life among breast cancer survivors 2 years after diagnosis: The relationship with adverse childhood events and posttraumatic growth,” Cancer Nurs., vol. 39, no. 3, pp. E32–E39, 2016, doi: 10.1097/NCC.0000000000000280.
[12] E. E. Bright and A. L. Stanton, “Prospective investigation of social support, coping, and depressive symptoms: A model of adherence to endocrine therapy among women with breast cancer.,” J. Consult. Clin. Psychol., vol. 86, no. 3, pp. 242–253, 2018, doi: 10.1037/ccp0000272.
[13] C. M. Davis, H. F. Myers, A. M. Nyamathi, M. Lewis, and M.-L. Brecht, “The Meaning of Survivorship as Defined by African American Breast Cancer Survivors,” J. Transcult. Nurs., vol. 27, no. 3, pp. 277–285, 2016, doi: 10.1177/1043659614561678.
[14] J. E. Haase et al., “The Resilience in Illness Model Part 2: Confirmatory Evaluation in Adolescents and Young Adults with Cancer,” Cancer Nurs., vol. 40, no. 6, pp. 454–463, 2017, doi: 10.1097/NCC.0000000000000450.
[15] R. J. Chan, P. Yates, and A. L. McCarthy, “Fatigue self-management behaviors in patients with advanced cancer: A prospective longitudinal survey,” Oncol. Nurs. Forum, vol. 43, no. 6, pp. 762–771, 2016, doi: 10.1188/16.ONF.762- 771.
[16] C. E. L. Jones, J. Maben, G. Lucas, E. A. Davies, R. H. Jack, and E. Ream, “Barriers to early diagnosis of symptomatic breast cancer: A qualitative study of Black African, Black Caribbean and White British women living in the UK,” BMJ Open, vol. 5, no. 3, 2015, doi: 10.1136/bmjopen-2014-006944.
[17] W. Chee et al., “A culturally tailored Internet cancer support group for Asian American breast cancer survivors: A randomized controlled pilot intervention study,” J. Telemed. Telecare, vol. 23, no. 6, pp. 618–626, 2017, doi: 10.1177/1357633X16658369.
[18] K. M. Kelly, R. Bhattacharya, S. Dickinson, and H. Hazard, “Health behaviors among breast cancer patients and survivors,” Cancer Nurs., vol. 38, no. 3, pp. E27–E34, 2015, doi: 10.1097/NCC.0000000000000167.
[19] H. Y. Park et al., “Psychological effects of a cosmetic education programme in patients with breast cancer,” Eur. J. Cancer Care (Engl)., vol. 24, no. 4, pp. 493–502, 2015, doi: 10.1111/ecc.12290.
[20] R. A. Shelby et al., “Testing a behavioral intervention to improve adherence to adjuvant endocrine therapy (AET),”
Contemp. Clin. Trials, vol. 76, pp. 120–131, 2019, doi: 10.1016/j.cct.2018.11.010.
[21] C. Wei, Y. Nengliang, W. Yan, F. Qiong, and C. Yuan, “The patient–provider discordance in patients’ needs assessment: a qualitative study in breast cancer patients receiving oral chemotherapy,” J. Clin. Nurs., vol. 26, no. 1–2,
pp. 125–132, 2017, doi: 10.1111/jocn.13374.
[22] H. Wouters et al., “Disentangling breast cancer patients’ perceptions and experiences with regard to endocrine therapy: Nature and relevance for non-adherence,” Breast, vol. 22, no. 5, pp. 661–666, 2013, doi: 10.1016/j.breast.2013.05.005.
[23] T. Y. Wu and C. Lin, “Developing and evaluating an individually tailored intervention to increase mammography adherence among Chinese American Women,” Cancer Nurs., vol. 38, no. 1, pp. 40–49, 2015, doi: 10.1097/NCC.0000000000000126.
[24] X. Bin Lai et al., “A Nurse-Led Care Program for Breast Cancer Patients in a Chemotherapy Day Center: A Randomized Controlled Trial,” Cancer Nurs., vol. 42, no. 1, pp. 20–34, 2019, doi: 10.1097/NCC.0000000000000539.
[25] C. E. Lee, D. Von Ah, B. Szuck, and Y. K. J. Lau, “Determinants of physical activity maintenance in breast cancer survivors after a community-based intervention,” Oncol. Nurs. Forum, vol. 43, no. 1, pp. 93–102, 2016, doi: 10.1188/16.ONF.43-01AP.
[26] M. K. Lee, Y. H. Yun, H. A. Park, E. S. Lee, K. H. Jung, and D. Y. Noh, “A Web-based self-management exercise and diet intervention for breast cancer survivors: Pilot randomized controlled trial,” Int. J. Nurs. Stud., vol. 51, no. 12,
pp. 1557–1567, 2014, doi: 10.1016/j.ijnurstu.2014.04.012.
[27] P. von Blanckenburg, F. Schuricht, U. S. Albert, W. Rief, and Y. Nestoriuc, “Optimizing expectations to prevent side effects and enhance quality of life in breast cancer patients undergoing endocrine therapy: Study protocol of a randomized controlled trial,” BMC Cancer, vol. 13, 2013, doi: 10.1186/1471-2407-13-426.
[28] D. Suwankhong and P. Liamputtong, “Breast cancer treatment: Experiences of changes and social stigma among Thai women in southern Thailand,” Cancer Nurs., vol. 39, no. 3, pp. 213–220, 2016, doi:
10.1097/NCC.0000000000000255.
[29] Y. Pan et al., “Facilitating adherence to endocrine therapy in breast cancer: Stability and predictive power of treatment expectations in a 2-year prospective study,” Breast Cancer Res. Treat., vol. 168, no. 3, pp. 667–677, 2018, doi: 10.1007/s10549-017-4637-2.
[30] M. O. Del Valle, R. Martin-Payo, A. Lana, J. B. Garcia, M. V. Folgueras, and M. L. Lopez, “Behavioural cancer risk factors in women diagnosed with primary breast cancer,” J. Adv. Nurs., vol. 70, no. 12, pp. 2810–2820, 2014, doi: 10.1111/jan.12433.
[31] H. Lee et al., “Using narrative intervention for HPV vaccine behavior change among Khmer mothers and daughters: A pilot RCT to examine feasibility, acceptability, and preliminary effectiveness,” Appl. Nurs. Res., vol. 40, pp. 51–60, 2018, doi: 10.1016/j.apnr.2017.12.008.
[32] E. Validity, “Downs and Black 1998 The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health.pdf,” pp. 377–384, 1998.
[33] T. E. Crane, T. A. Badger, A. Sikorskii, C. Segrin, C. H. Hsu, and A. G. Rosenfeld, “Trajectories of depression and anxiety in latina breast cancer survivors,” Oncol. Nurs. Forum, vol. 46, no. 2, pp. 217–227, 2019, doi: 10.1188/19.ONF.217-227.
[34] L. K. Schell, I. Monsef, A. Wöckel, and N. Skoetz, “Mindfulness-based stress reduction for women diagnosed with breast cancer,” Cochrane Database Syst. Rev., vol. 2019, no. 3, 2019, doi: 10.1002/14651858.CD011518.pub2.
[35] B. B. Germino et al., “Outcomes of an uncertainty management intervention in younger African American and caucasian breast cancer survivors,” Oncol. Nurs. Forum, vol. 40, no. 1, pp. 82–92, 2013, doi: 10.1188/13.ONF.82-92.
[36] X. T. N. Ha, S. Thanasilp, and R. Thato, “The effect of uncertainty management program on quality of life among Vietnamese women at 3 weeks postmastectomy,” Cancer Nurs., vol. 42, no. 4, pp. 261–270, 2019, doi: 10.1097/NCC.0000000000000597.
[37] C. G. Shields et al., “An intervention to improve communication between breast cancer survivors and their physicians,” J. Psychosoc. Oncol., vol. 28, no. 6, pp. 610–629, 2010, doi: 10.1080/07347332.2010.516811.
[38] S. Krikorian et al., “Adherence to oral chemotherapy: Challenges and opportunities,” J. Oncol. Pharm. Pract., vol. 25, no. 7, pp. 1590–1598, 2019, doi: 10.1177/1078155218800384.
[39] A. S. Ahadzadeh and S. P. Sharif, “Uncertainty and quality of life in women with breast cancer: Moderating role of coping styles,” Cancer Nurs., vol. 41, no. 6, pp. 484–490, 2018, doi: 10.1097/NCC.0000000000000552.
Downloads
Published
Issue
Section
License
This work is licensed under a Creative Commons Attribution 4.0 International License.
You are free to:
- Share — copy and redistribute the material in any medium or format for any purpose, even commercially.
- Adapt — remix, transform, and build upon the material for any purpose, even commercially.
- The licensor cannot revoke these freedoms as long as you follow the license terms.
Under the following terms:
- Attribution — You must give appropriate credit , provide a link to the license, and indicate if changes were made . You may do so in any reasonable manner, but not in any way that suggests the licensor endorses you or your use.
- No additional restrictions — You may not apply legal terms or technological measures that legally restrict others from doing anything the license permits.
Notices:
You do not have to comply with the license for elements of the material in the public domain or where your use is permitted by an applicable exception or limitation .
No warranties are given. The license may not give you all of the permissions necessary for your intended use. For example, other rights such as publicity, privacy, or moral rights may limit how you use the material.
